# OnCo record bighat-biosciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/bighat-biosciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "bighat-biosciences" ;
  schema:name "BigHat Biosciences"@en ;
  schema:description "BigHat uses machine learning and a fast automated lab to design antibodies. Its first cancer drug, an antibody carrying a chemotherapy payload to stomach and bowel tumours, entered human trials in 2026."@en ;
  schema:url <https://onco.cc/companies/bighat-biosciences/>, <https://www.bighatbio.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.bighatbio.com>, <https://bighatbio.com/news/bighat-biosciences-announces-first-patient-dosed-in-phase-1-trial-evaluating-bhb810>, <https://bighatbio.com/news> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/ai-computation/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/ai-drug-design/> ;
  onco:trials <https://onco.cc/trials/nct07529808/> .